Endoscopic Resection of Bladder Tumors

Hopital Foch68 enrolled

Overview

To confirm the benefit of endoscopic resection under fluorescence and blue light of high grade non-muscle invasive bladder tumor, and verifying if the second endoscopic resection recommended nowadays can be deleted.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Bladder Tumor

Interventions

Endoscopic resection under blue light (Hexvix®)OTHER

Endoscopic resection

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- 18 year-old and older male and female subjects having high grade non-muscle invasive bladder tumor, with urinary cytology , imaging examination (Ultrasound, urography, or scan) and endoscopic examination Exclusion Criteria: \- Less than 18 years of age, and having no: * Non-muscle invasive tumor, and of low grade. * Bladder tumor infiltrating the muscular layer shown by pre-operative test, with absence of urinary cytology * No blue light source in sustainable way

Locations (1)

Hôpital FOCH

Suresnes, France

Outcomes

Primary Outcomes

Number of extra lesions revealed by blue light compared to the resection performed in white light

Time frame: 2 to 6 weeks after resection

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.